β-Rubromycin
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


β-Rubromycin
Description:
β-Rubromycin, a quinone antibacterial agent, is a selective HIV-1 reverse transcriptase inhibitor with a Ki of 0.27 μM. β-Rubromycin is a potent telomerase inhibitor with an IC50 of 3 μM. β-Rubromycin inhibits the proliferation of both K-562 and HeLa cells with IC50 values of 19.5 µM and 22.7 µM, respectively[1][2].UNSPSC:
12352005Hazard Statement:
H302+H312-H319-H351Target:
Bacterial; HIV; Reverse Transcriptase; TelomeraseType:
Reference compoundRelated Pathways:
Anti-infection; Cell Cycle/DNA DamageApplications:
COVID-19-anti-virusField of Research:
Cancer; Infection; Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/β-rubromycin.htmlPurity:
97.7Solubility:
DMSO : 1 mg/mL (ultrasonic; warming)Smiles:
O=C(C(O1)=CC(C=C(CC[C@@]2(OC(C3=O)=C(C(C4=C3C(O)=C(OC)C=C4OC)=O)C2)O5)C5=C6O)=C6C1=O)OCMolecular Formula:
C27H20O12Molecular Weight:
536.44Precautions:
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P405-P501References & Citations:
[1]Goldman ME, et al. Inhibition of human immunodeficiency virus-1 reverse transcriptase activity by rubromycins: competitive interaction at the template.primer site. Mol Pharmacol. 1990;38 (1) :20-25.|[2]Ueno T, et al. Inhibition of human telomerase by rubromycins: implication of spiroketal system of the compounds as an active moiety. Biochemistry. 2000 May 23;39 (20) :5995-6002.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Scientific Category:
Reference compound1Clinical Information:
No Development ReportedIsoform:
HIV-1CAS Number:
[27267-70-5]
